Company
Eikonizo Therapeutics
Envisioning life-changing therapies for neurodegenerative and cardiorenal diseases
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Cambridge, MA, United States
- eikonizo.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Eikonizo is developing disease-modifying therapies by creating brain penetrant and peripheral small molecules to improve the lives of people impacted by neurodegenerative, cardiorenal and other diseases.
Funding snapshot
- Latest round
- Undisclosed2024-12-10
Funding rounds
- Round, 2024
- 2024-12-10
Products
- Other
- EKZ-102
Loading relationship preview